Michelle Perello
Pulmonary Disease · Chesapeake, VANPI 1396709655
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,507 of the $1,703 with a category attached, or 88.5%. It is spread thinly across 25 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for pulmonary disease clinicians in VA, where the typical reported total is $1,962.
Across 75 payments — averaging $22.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$219
- AstraZeneca$177
- Astellas Pharma US Inc$154
- Jazz Pharmaceuticals Inc.$152
- Genentech USA, Inc.$97
- Regeneron Healthcare Solutions, Inc.$96
- plus $808 from 19 others
What the payments were for
- Food & beverage$1,50788%
- Education$19612%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 13 | $219 |
| AstraZeneca | 11 | $177 |
| Astellas Pharma US Inc | 3 | $154 |
| Jazz Pharmaceuticals Inc. | 4 | $152 |
| Genentech USA, Inc. | 4 | $97 |
| Regeneron Healthcare Solutions, Inc. | 3 | $96 |
| Baxter Healthcare | 2 | $83 |
| Grifols USA, LLC | 3 | $80 |
| Novartis | 3 | $71 |
| Sanofi-aventis U.S. LLC | 1 | $57 |
| Mylan Specialty L.p. | 3 | $57 |
| Resmed Corp | 3 | $56 |
| ANI Pharmaceuticals, Inc. | 2 | $55 |
| Advanced Respiratory, Inc | 3 | $47 |
| Electromed, Inc. | 3 | $46 |
| Insmed, Inc. | 3 | $37 |
| Inogen, Inc. | 2 | $36 |
| Boehringer Ingelheim | 2 | $32 |
| Philips North America LLC | 1 | $27 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| Bayer | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Circassia Inc. | 1 | $20 |
| Merck | 1 | $18 |
| Itamar Medical Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYWAV$110
How this compares
$1,703 in reported general payments places this provider in the 45th percentile of 317 pulmonary disease providers in Virginia.
Other pulmonary disease in Chesapeake
- Carlos SilvaChesapeake$245K
- Himanshu DesaiChesapeake$174K
- Steven NathanFalls Church$1.5M
- Omar MinaiHopewell$1.3M
- Rabih HalabiFalls Church$604K
- Eric LibreAnnandale$302K
- Sujoy GillRichmond$296K
- Imre NothCharlottesville$256K
- Vijay SubramaniamWilliamsburg$228K
- Ellen VolkerCharlottesville$177K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.